Protein calorie malnutrition (PCM), which is one of the major and most characteristic problems of cancer bearing patients, produces broad effects on the host immune defences. Defects in humoral immunity, mucosal immunity and phagocytic cell function have been identified, but the weight of evidence suggests that cell-mediated immunity is most profoundly impaired (Law et al., 1973; Keusch et al., 1978; Gross & Newberne, 1980; Martin et al., 1983; Chandra, 1989 ). In particular, depressed NK activity and unresponsiveness to interferon have been reported in PBMC of infants with PCM, as well as in acute starvation (Salimonou et al., 1983; Schattner et al., 1990) .
The aim of this research was to examine the role of PCM in the genesis of tumour associated immunodeficiency. Because of the importance of NK cells in the early defence against infectious and malignant diseases and in the in vivo destruction of circulating tumour emboli (Seaman et al., 1987) we decided to analyse how PCM impairs NK cell cytotoxicity in cancer bearing patients. Malnourished cancer patients, showing about 10-20% reduction of body weight in the last 6 months were studied; two control groups were identified: (1) cancer patients without malnutrition and (2) normal, healthy subjects. Both the basal NK activity of PBMC and the effects of in vitro treatment with rIL-2 and alfa-rIFN were examined. The ability of PBMC from the same patients to produce IL-2 in response to a panel of antigens was also measured in order to recognise any possible correlation between NK and T helper (Th) cell functions.
Materials aifd methods

Special reagents
Highly purified human recombinant IL-2 (rIL-2) was provided by the Biogen (Cambridge, MA); recombinant human Interferon alfa 2a (alfa-rIFN) was provided by Roche (Basel, CH); anti-TAC and fluorescinated anti-Leu.7 monoclonal antibodies (MoAB) were from Becton Dickinson (Sunnyvale, CA).
Patients
The patients were hospitalised at the Istituto nazionale Tumori of Milano (1987 Milano ( -1989 The immune parameters of a group of ten MN cancer patients, which underwent parenteral nutrition, were also evaluated both prior and after the 10 day treatment period. The parenteral nutrition regimen included a non protein calorie load equal to 150% of the estimated resting energy expenditure with a calorie to nitrogen ratio of 150:1 and was delivered according to the commonly accepted guidelines (Bozzetti, 1989 
Effects ofparenteral nutrition on NK activity
To further examine the influence of nutrition on NK activity, the immunological status of a group of ten patients was evaluated before and after 10 days of treatment. The results are shown in Table I . In all patients NK activity quickly improved after parenteral nutrition. The mean values of cytotoxic activity, expressed as percentage lysis, increased from 37.6 ± 8.7 to 54.5 ± 9.7 for basal, from 56.5 ± 9.9 to 70.3 ± 8.5 for alfa-rIFN stimulated and from 75.0 ± 8.4 to 82.9 ± 3.6 for rIL-2 stimulated activity. holds, calculated as mean value of absolute c.p.m. of healthy controls -2 s.d. were as follows: (1) 52.3 for basal; (2) 69.8 for alfa-rIFN and (3) 81.9 for rIL-2 stimulated NK activity. After parenteral nutrition, as many MN cancer patients as 5.10 for basal and 7/10 for rIL-2 stimulated NK activity, but only 3/10 for alfa-rIFN stimulated NK activity showed a response over the normal thresholds. It can be concluded that parenteral nutrition corrected NK activity to normal in several MN patients; the most sensitive to this correction was the responsiveness to rIL-2 stimulation, while the most refractory was that to alfa-rIFN stimulation.
Discussion
Our results show that (1) PCM in cancer bearing patients is associated with a marked decrease of their NK cell activity as compared to healthy controls (29.3 ± 14.9 vs 65.2 ± 6.0 percent lysis, respectively) ( Figure 1) ; (2) (Figure 2 ). The rIL-2 stimulated PBMC from WN cancer patients behave like those from controls. On the other hand, the cytotoxic activity of PBMC from MN cancer patients is only moderately enhanced by incubation with alfa-rIFN; in a few cases it reaches the normal basal threshold and in no cases at all it goes over the threshold of alfa-rIFN stimulated normal PBMC (Figure 2 ). It can be concluded that rIL-2, but not rIFN, is able to restore the NK activity of MN cancer patients.
The impairment of NK activity in MN cancer patients is rapidly corrected by nutritional repletion. After 10 days of parenteral administration of proper amounts Qf protein and calories, the basal NK activity shows a marked increase, if compared to that observed prior to renutrition (mean values from 58% to 83% of healthy controls prior and after renutrition respectively); the rIL-2 stimulated activity is almost always normalised while the alfa-rIFN stimulated activity is normalised in a minority of cases, thus appearing more refractory to correction. We are unable to explain the different PBMC sensitivity of MN cancer patients to rIL-2 or to alfa-rIFN, which was observed both prior and after nutritional recovery. We recall that a decreased responsiveness to IFN, often associated with a good reactivity to IL-2, has been observed in' other clinical situations with PCM such as malnourished infants or adults with liver cirrhosis (Charpentier et al., 1984) or in several diseases with reduced NK cell activity, such as EBV and HIV infections (Purtilo et al., 1985; Rook et al., 1985) and in common variable hypogammaglobulinemia (Clerici et al., 1988) . In malnourished children the nutritional recovery completely corrects both the basal NK activity and the responsiveness to IFN (Salimonou et al., 1983 CD4 + and CD8 + Th together with allologous or autologous APC; in contrast, the response to PHA utilises both CD4 + and CD8 + Th, but is less dependent on APC. The results show that the IL-2 production is decreased in some but not in all MN cancer patients as compared to controls; the most affected are the responses to recall antigen FLU, while those to ALLO and PHA are less influenced. However, the level of the IL-2 production does not correlate in any case with both basal and rIL-2 or rIFN activated NK activity. This suggests that the depression of NK activity in MN cancer patients is not dependent from the decreased production of endogenous IL-2.
In conclusion, our results show that malnutrition plays a major role in the regulation of the immune response of cancer bearing patients and that the impairment of natural cytotoxicity, as reported in the literature, is more correctly referable to PCM rather that to malignancy itself. The mechanism responsible of the depressed NK activity in MN cancer patients is not known. In principle, it may be amenable to (1) lack of essential nutrients for RNA and protein synthesis or for other metabolic processes necessary both for NK function and activitation and (2) release of some specific factors associated with cancer, such as TNF, which can cause contemporaneously PCM and NK activity depression (Beutler, 1988; Plata-Salaman et al., 1988; Vaisman, 1989; Gordon & Wofsy, 1990) . For the time being, we chose to explore this latter hypothesis examining if changes in TNF production in MN cancer patients, if present, may correlate with NK activity depression.
